Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation.
Peverelli E
Cancer Lett. 2016 Aug 9;381(2):279-86. doi: 10.1016/j.canlet.2016.08.005
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.
Peverelli E
Int J Cancer. 2017 Feb 8;140(8):1870-1880. doi: 10.1002/ijc.30613
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression.
Vitali E
Oncotarget. 2017 Aug 24;8(44):77330-77340. doi: 10.18632/oncotarget.20473
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment.
Peverelli E
Int J Cancer. 2017 Dec 20;142(9):1842-1852. doi: 10.1002/ijc.31205
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.
Peverelli E
Cancer Lett. 2018 Aug 8;435:101-109. doi: 10.1016/j.canlet.2018.08.002
Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells.
Treppiedi D
Neuroendocrinology. 2019 Oct 1;110(7-8):642-652. doi: 10.1159/000503791
A human memory T cell subset with stem cell-like properties.
Gattinoni L
Nat Med. 2011 Sep 18;17(10):1290-7. doi: 10.1038/nm.2446
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
Conlon KC
J Clin Oncol. 2014 Nov 17;33(1):74-82. doi: 10.1200/JCO.2014.57.3329
High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors.
Brummelman J
J Exp Med. 2018 Aug 28;215(10):2520-2535. doi: 10.1084/jem.20180684
Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity.
Pilipow K
JCI Insight. 2018 Sep 20;3(18)pii: 122299. doi: 10.1172/jci.insight.122299